Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- ChecktodayChange DetectedNew history entries on 2025-11-24 add Contacts/Locations and Study Status, along with Revision: v3.3.2. The prior Revision: v3.2.0 has been removed.SummaryDifference0.3%

- Check7 days agoChange DetectedAdded 2025-11-07 entry with Contacts/Locations and Study Status (version 142).SummaryDifference0.3%

- Check15 days agoChange DetectedNew history entries on 2025-11-04 and 2025-11-05 add updates to Study Status and Contacts/Locations (versions 140 and 141). These updates reflect the current administrative details of the trial.SummaryDifference0.3%

- Check22 days agoChange DetectedOn 2025-10-30, Contacts/Locations and Study Status were added. A deletion occurred on 2025-10-24, and an entry labeled 139 was added on 2025-10-29.SummaryDifference0.2%

- Check29 days agoChange DetectedNew entries for Study Status and Contacts/Locations were added on 2025-10-23 and 2025-10-24, and the 2025-10-22 entry was removed.SummaryDifference0.1%

- Check43 days agoChange Detected- Added new dated study status sections (2025-10-10, 136 2025-10-09, 135 2025-10-07) and their headers. - Removed an older entry (2025-10-02).SummaryDifference0.9%

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.